home.social

#mappbiopharmaceutical — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #mappbiopharmaceutical, aggregated by home.social.

fetched live
  1. Benjamin Carr, Ph.D. 👨🏻‍💻🧬 @[email protected] ·

    #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

    #us #sandiego #biotech #ebola #mappbiopharmaceutical #ebolavirus
  2. Benjamin Carr, Ph.D. 👨🏻‍💻🧬 @[email protected] ·

    #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

    #us #sandiego #biotech #ebola #mappbiopharmaceutical #ebolavirus
  3. Benjamin Carr, Ph.D. 👨🏻‍💻🧬 @BenjaminHCCarr ·

    taps small for experimental treatment as epidemic worsens
    Biotech, , “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of separate from the species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

    #us #sandiego #biotech #ebola #mappbiopharmaceutical #ebolavirus
  4. Benjamin Carr, Ph.D. 👨🏻‍💻🧬 @[email protected] ·

    #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

    #bundibugyo #ebolavirus #mappbiopharmaceutical #ebola #biotech #sandiego
  5. Benjamin Carr, Ph.D. 👨🏻‍💻🧬 @[email protected] ·

    #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

    #us #sandiego #biotech #ebola #mappbiopharmaceutical #ebolavirus